Latest Articles
15 Kenyans Convicted In The U.S. Face Swift Deportation Under A New Immigration Crackdown Beşiktaş Vs Trabzonspor (udFAuIRQN2) - Mshale
15 Kenyans Convicted In The U.S. Face Swift Deportation Under A New Immigration Crackdown Beşiktaş Vs Trabzonspor (udFAuIRQN2) Mshale
Published: June 23, 2026, 1:36 a.m.
Nashik: Advanced ‘MIGS’ Department Operational At Ashoka Hospital - Free Press Journal
Nashik: Advanced ‘MIGS’ Department Operational At Ashoka Hospital Free Press Journal
Published: June 22, 2026, 12:19 p.m.
Medicus Pharma to Showcase SkinJect® Registrational Strategy and Teverelix® Precision Medicine Program at Bio International 2026 - The Manila Times
Medicus Pharma to Showcase SkinJect® Registrational Strategy and Teverelix® Precision Medicine Program at Bio International 2026 The Manila Times
Published: June 22, 2026, 11:48 a.m.
Medicus Pharma to Showcase SkinJect® Registrational - GlobeNewswire
Medicus Pharma to Showcase SkinJect® Registrational GlobeNewswire
Published: June 22, 2026, 11:30 a.m.
Queensland Civil and Administrative Tribunal (QCAT) hearings for Monday, June 22 - Townsville Bulletin
Queensland Civil and Administrative Tribunal (QCAT) hearings for Monday, June 22 Townsville Bulletin
Published: June 21, 2026, 10:30 p.m.
Is Absci Corporation (ABSI) A Good Stock To Buy Now? - Insider Monkey
Is Absci Corporation (ABSI) A Good Stock To Buy Now? Insider Monkey
Published: June 21, 2026, 2:43 p.m.
Surgery bombshell: Doctors now ‘too scared’ to do this important operation - Herald Sun
Surgery bombshell: Doctors now ‘too scared’ to do this important operation Herald Sun
Published: June 20, 2026, noon
Push to scrap Victoria’s lucrative hidden mobile speed cameras - Herald Sun
Push to scrap Victoria’s lucrative hidden mobile speed cameras Herald Sun
Published: June 19, 2026, 8:47 p.m.
Surgery bombshell: Why doctors ‘too scared’ to do this operation on women - Herald Sun
Surgery bombshell: Why doctors ‘too scared’ to do this operation on women Herald Sun
Published: June 19, 2026, 8:33 p.m.
Nivolumab Produces 68% Clinical CR Rate in Resectable dMMR Endometrial Cancer - OncLive
Nivolumab Produces 68% Clinical CR Rate in Resectable dMMR Endometrial Cancer OncLive
Published: June 19, 2026, 5:49 p.m.
Link copied to clipboard!